Isomorphic Labs plans to raise over $2 billion, led by Thrive Capital

According to insiders, Isomorphic Labs, an AI drug discovery company spun off from Google's DeepMind, is discussing a new round of funding and plans to raise over $2 billion. Thrive Capital will lead this financing, and Alphabet will also participate. The financing has not yet ended.